Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)

Informazioni relative al progetto

OVADEX

ID dell’accordo di sovvenzione: 101064216

DOI

10.3030/101064216

Progetto chiuso

Data della firma CE 9 Giugno 2022

Data di avvio 1 Settembre 2022

Data di completamento 31 Agosto 2024

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 175 920,00

Coordinato da

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (1)

Communication, Dissemination & Outreach Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected processed or generated by the action It is adocument describing what data will be collected processed or generated andfollowing what methodology and standards whether and how this data will beshared andor made open and how it will be curated and preserved

Pubblicazioni

Peer reviewed articles (3)

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)

Autori: Trozzi, Rita; Tuyaerts, Sandra; Annibali, Daniela; Pomares, Alejandro Herreros; Boog, Lotte; Van Dam, Peter; Leunen, Karin; Deroose, Christophe; Trum, Hans; Amant, Frederic
Pubblicato in: International Journal Of Gynecological Cancer, Numero 34 (8), 1217-1224, 2024, ISSN 1525-1438
Editore: BMJ PUBLISHING GROUP
DOI: 10.1136/IJGC-2023-005229

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6^high uterine leiomyosarcoma to PD‐1 blockade

Autori: Wout De Wispelaere; Daniela Annibali; Sandra Tuyaerts; Julie Messiaen; Asier Antoranz; Gautam Shankar; Nikolina Dubroja; Alejandro Herreros‐Pomares; Regina E. M. Baiden‐Amissah; Marie‐Pauline Orban; Marcello Delfini; Emanuele Berardi; Thomas Van Brussel; Rogier Schepers; Gino Philips; Bram Boeckx; Maria Francesca Baietti; Luigi Congedo; Kiave Yune HoWangYin; Emilie Bayon; Anne‐Sophie Van Rompuy; Eleonora Leucci; Sebastien P. Tabruyn; Francesca Bosisio; Massimiliano Mazzone; Diether Lambrechts; Frédéric Amant
Pubblicato in: Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024), Numero 14(5) e1655, 2024, ISSN 2001-1326
Editore: JONH WILEY & SONS LTD
DOI: 10.1002/CTM2.1655

Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer

Autori: María Castaño; Sarai Tomás-Pérez; Eva González-Cantó; Cristina Aghababyan; Andrea Mascarós-Martínez; Nuria Santonja; Alejandro Herreros-Pomares; Julia Oto; Pilar Medina; Martin Götte; Bárbara Andrea Mc Cormack; Josep Marí-Alexandre; Juan Gilabert-Estellés
Pubblicato in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Numero 24(6), 5995, 2023, ISSN 1661-6596
Editore: MDPI
DOI: 10.3390/IJMS24065995